Tessellate Bio

Tessellate BIO is a preclinical-stage biotechnology company headquartered in Nardeen, the Netherlands, with research laboratories located at the Stevenage Bioscience Catalyst in the UK. Tessellate BIO was established to develop precise oncology approaches for treating cancers with significant unmet needs. Under the leadership of CEO Andree Blaukat, Tessellate BIO discovers and develops novel precision oncology drugs targeting pathways beyond HRD.